KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Operating Expenses: 2010-2025

Historic Operating Expenses for Incyte (INCY) over the last 16 years, with Sep 2025 value amounting to $922.5 million.

  • Incyte's Operating Expenses fell 6.99% to $922.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 billion, marking a year-over-year decrease of 19.28%. This contributed to the annual value of $4.2 billion for FY2024, which is 35.92% up from last year.
  • Incyte's Operating Expenses amounted to $922.5 million in Q3 2025, which was up 34.62% from $685.2 million recorded in Q2 2025.
  • In the past 5 years, Incyte's Operating Expenses ranged from a high of $1.5 billion in Q2 2024 and a low of $505.9 million during Q1 2021.
  • Moreover, its 3-year median value for Operating Expenses was $826.1 million (2023), whereas its average is $882.8 million.
  • Per our database at Business Quant, Incyte's Operating Expenses tumbled by 58.95% in 2021 and then surged by 100.03% in 2024.
  • Over the past 5 years, Incyte's Operating Expenses (Quarterly) stood at $752.1 million in 2021, then grew by 13.89% to $856.6 million in 2022, then dropped by 3.56% to $826.1 million in 2023, then increased by 6.19% to $877.2 million in 2024, then fell by 6.99% to $922.5 million in 2025.
  • Its Operating Expenses stands at $922.5 million for Q3 2025, versus $685.2 million for Q2 2025 and $847.7 million for Q1 2025.